Treatment of aortoiliac occlusive disease: Medical versus endovascular versus surgical therapy

被引：10

作者：

Moise M.A. ^{[1
]}

Kashyap V.S. ^{[1
,2
]}

机构：

[1] Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, 9500 Euclid Avenue

[2] Division of Vascular Surgery and Endovascular Therapy, University Hospitals, Case Medical Center, Cleveland, OH 44106, 11100 Euclid Ave

来源：

Current Treatment Options in Cardiovascular Medicine | 2011年 / 13卷 / 2期

关键词：

Peripheral Arterial Disease; Cilostazol; Critical Limb Ischemia; Intermittent Claudication; Endovascular Therapy;

D O I：

10.1007/s11936-011-0117-x

中图分类号：

学科分类号：

摘要：

Opinion Statement: Aortoiliac occlusive disease (AIOD) is an insidious, progressive atherosclerotic process that can lead to claudication, rest pain, tissue loss, and eventual lower extremity amputation. The patient with AIOD is also at risk for both fatal and nonfatal cardiovascular events. Treatment of the disease includes both risk factor modification and efforts to improve blood flow to the lower extremity. For mild to moderate intermittent claudication, medical therapy as well as a supervised exercise program is advised. For debilitating claudication or critical limb ischemia, a number of recent studies support an endovascular approach for patients with AIOD, citing patency rates that compare favorably to open surgery. Surgical revascularization, however, should still be considered in selected patients. © 2011 Springer Science+Business Media, LLC.

引用

页码：114 / 128

页数：14

共 46 条

[1]

Selvin E., Erlinger T.P., Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2000, Circulation, 110, 6, pp. 738-743, (2004)

[2]

Murabito J.M., Evans J.C., Nieto K., Larson M.G., Levy D., Wilson P.W.F., Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study, American Heart Journal, 143, 6, pp. 961-965, (2002)

[3]

Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G.R., Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), European Journal of Vascular and Endovascular Surgery, 33, 1 SUPPL., (2007)

[4]

Raffetto J.D., Montgomery J.E., Eberhardt R.T., LaMorte W.W., Menzoian J.O., Differences in risk factors for lower extremity arterial occlusive disease, Journal of the American College of Surgeons, 201, 6, pp. 918-924, (2005)

[5]

Aboyans V., Desormais I., Lacroix P., Et al., The general prognosis of patients with peripheral arterial disease differs according to the disease localization, J Am Coll Cardiol, 55, 9, pp. 898-903, (2010)

[6]

Skau T., Johnsson B., Prevalence of symptomatic leg ischaemia in a Swedish community - An epidemiological study, European Journal of Vascular Surgery, 7, 4, pp. 432-437, (1993)

[7]

Fowkes F.G., Housley E., Cawood E.H., Et al., Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population, Int J Epidemiol, 20, pp. 384-92, (1991)

[8]

Kannel W.B., Skinner J.J., Schwartz Jr. M.J., Shurtleff D., Intermittent claudication. Incidence in the Framingham Study, Circulation, 41, 5, pp. 875-83, (1970)

[9]

Ness J., Aronow W.S., Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice, Journal of the American Geriatrics Society, 47, 10, pp. 1255-1256, (1999)

[10]

Criqui M.H., Langer R.D., Fronek A., Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease, N Engl J Med, 326, 6, pp. 381-386, (1992)

← 1 2 3 4 5 →